National Overprescribing Review implementation evaluation - patient survey and insights feasibility study
Estimated value
£50k
Awarded value
£44k
Awarded 10 Mar 2022
Suppliers
1
Lots
1
1 awarded
Published
30 Mar 2022
Deadline 25 Feb 2022
Description
The Authority is looking for a Supplier for the provision of a feasibility study to determine how patient insights and feedback are best provided in relation to prescribing of medicines .
Scope
- Reference
- CF-0740200D0O000000rwimUAA1
- Total value
- £50,000 excluding VAT
- Commercial tool
- Standalone contract
- Contract dates
- 14 Mar 2022 to 05 Jun 2022
- CPV classifications
- 85100000 79314000 33195000 73110000
- Particular suitability
- Small and medium-sized enterprises (SME)
Submission & procedure
- Submission deadline
- 25 Feb 2022, 12:00 pm
Award details
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
£44k
Award date
10 Mar 2022
Contract start
14 Mar 2022
Contract end
05 Jun 2022
Awarded to
Awarded suppliers· 1 supplier
Awarded 10 Mar 2022 · Contract period 14 Mar 2022 — 05 Jun 2022
Award value
£44k
Other contracts from NHS England
Full notice and award history for this contracting authority is on the buyer profile.
Other contracts awarded to Woodnewton· 3
Cross-buyer view of this supplier's public-sector wins.
| Title | Type | Value | Published |
|---|---|---|---|
| MHRA Customer & Stakeholder Insights Research (DPS CCS RM6126) 2025 | contract | £1.2m | 08 Apr 2025 |
| Customer and Stakeholder Insights Research - DPS Competition CCS RM6126 | contract | £530k | 09 Jun 2023 |
| National Overprescribing Review implementation evaluation - healthcare professional survey and insights feasibility study | contract | £47k | 30 Mar 2022 |